March 31st, 2014
Are We Equipped to Make a CHOICE Between TAVR Devices?
E Murat Tuzcu, MD
E. Murat Tuzcu offers his perspective on the CHOICE trial comparing the CoreValve and Edwards Sapien XT devices for transcatheter aortic valve replacement.
February 21st, 2014
Unpacking a Systematic Review of TAVR Research
Philip Green, MD and Kumar Dharmarajan, MD MBA
Philip Green and Kumar Dharmarajan explore how best to identify which patients benefit most from transcatheter aortic valve replacement.
October 29th, 2013
Pivotal Results for Medtronic’s CoreValve
Larry Husten, PHD
Key data on what will likely be the second transcatheter aortic valve to gain approval in the U.S. were presented today at the Transcatheter Cardiovascular Therapeutics (TCT) 2013 Conference in San Francisco. Jeffrey Popma, co-principal investigator of the trial, presented the major results from the CoreValve U.S. Pivotal Trial in patients who were too ill or frail for traditional open […]
June 3rd, 2013
How Do Patients with CAD Fare After TAVR?
Sachin Goel, MD and Erica Sarah Spatz, MD, MHS
Sachin Goel discusses his research group’s literature review focusing on patients with coronary artery disease who are evaluated for — and those who undergo — transcatheter aortic valve replacement.
NEJM Journal Watch — Recent Cardiology Articles- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?